Synapse Biomedical Revenue and Competitors

Oberlin, OH USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Synapse Biomedical's estimated annual revenue is currently $9.3M per year.(i)
  • Synapse Biomedical's estimated revenue per employee is $290,219

Employee Data

  • Synapse Biomedical has 32 Employees.(i)
  • Synapse Biomedical grew their employee count by 7% last year.

Synapse Biomedical's People

NameTitleEmail/Phone
1
Chief Operating Officer & EU Managing Director & Board Directors, SecretaryReveal Email/Phone
2
VP Product Development/OperationsReveal Email/Phone
3
Director Quality & Regulatory AffairsReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Sr Director Quality and Process DevelopmentReveal Email/Phone
6
Clinical Services ManagerReveal Email/Phone
7
Clinical Services ManagerReveal Email/Phone
8
Technical Documentation ManagerReveal Email/Phone
9
Market PresidentReveal Email/Phone
10
COO/Managing Director-EuropeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$470.6M15924%N/AN/A
#2
$16.3M530%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M1417%N/AN/A
#5
$21.1M68-1%N/AN/A
#6
$70M2798%N/AN/A
#7
$4M130%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$11.5M4211%N/AN/A
#10
$8.8M3535%N/AN/A
Add Company

What Is Synapse Biomedical?

Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency. This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in Spinal Cord Injuries, in the diaphragm conditioning in muscular dystrophies (such as ALS) and in respiratory short-term intensive care settings.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$9.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synapse Biomedical News

2022-04-17 - Global Neuromodulation Devices And Implantable Infusion ...

... Implantable Infusion Pumps Market 2022 Industry Development – Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation.

2022-04-17 - Sacral Nerve Stimulation Market Size And Forecast | Nuvectra ...

... Technologies Inc., Nevro Corp., Boston Scientific Corporation, Synapse Biomedical Inc., St. Jude Medical Inc, Johnson and Johnson.

2022-04-17 - Global Diaphragm Pacing Device Market 2022 Growth ...

Product Application. SCI, ALS, Other. Classified into key participants. Avery Biomedical Devices, Synapse Biomedical, Atrotech, Arahelio,.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3841%N/A
#2
N/A3831%N/A
#3
$8.3M4712%N/A
#4
$10.8M500%N/A
#5
$11.2M56-2%N/A